Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Extension of Epoetin Alfa in Anemia of Chronic Disease due to RA
NCT00123149Phase 2Withdrawn
- Sponsor
- Ortho Biotech Inc.
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa in anemia of chronic disease (ACD), sponsored by Ortho Biotech Inc.. Status: withdrawn.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT00123149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123149.